SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-23-002000
Filing Date
2023-03-13
Accepted
2023-03-13 12:01:51
Documents
13
Period of Report
2023-03-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K soulbiotechno_8k.htm   iXBRL 8-K 38263
2 EXHIBIT 99.1 soulbiotechno_ex99-1.htm EX-99.1 15283
  Complete submission text file 0001829126-23-002000.txt   224512

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adob-20230313.xsd EX-101.SCH 3236
4 XBRL LABEL FILE adob-20230313_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adob-20230313_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT soulbiotechno_8k_htm.xml XML 3278
Mailing Address 36 FOURTH AVE. N SASKATCHEWAN A9 S3N 2V7
Business Address 36 FOURTH AVE. N SASKATCHEWAN A9 S3N 2V7 (516) 544-2812
Soul Biotechnology Corp (Filer) CIK: 0001726822 (see all company filings)

IRS No.: 823155323 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56213 | Film No.: 23726472
SIC: 2833 Medicinal Chemicals & Botanical Products